```html

Zoster Ophthalmicus Eye Pain

What is Zoster ophthalmicus eye pain?

Zoster ophthalmicus (ZO) is a painful, often blistering infection of the eye and surrounding facial structures caused by re‑activation of the varicella‑zoster virus (VZV) – the same virus that causes chickenpox and shingles. When the virus re‑emerges in the ophthalmic division of the trigeminal (cranial nerve V) nerve, it can involve the cornea, conjunctiva, eyelid, and deeper ocular structures. The hallmark symptom is intense, burning or throbbing eye pain that can be accompanied by visual changes.

Because the eye is a delicate organ, ZO can lead to serious complications such as keratitis, uveitis, glaucoma, or even permanent vision loss if not recognized promptly. The condition is most common in adults over 50 or in anyone with weakened immunity.

Common Causes

While the primary cause of Zoster ophthalmicus eye pain is VZV reactivation, several factors increase the risk of developing ZO or of experiencing eye pain that mimics it. Below are the most frequent contributors:

• Varicella‑zoster virus reactivation – the direct cause of ZO.
• Advanced age – immune surveillance declines after age 50.
• Immunosuppression – HIV/AIDS, chemotherapy, organ transplantation, corticosteroid therapy.
• Stress or trauma – emotional or physical stress can trigger viral reactivation.
• Previous shingles outbreak – especially if it involved the face.
• Chronic ocular surface disease – dry eye, blepharitis can make the cornea more vulnerable.
• Autoimmune diseases – e.g., systemic lupus erythematosus, rheumatoid arthritis.
• Diabetes mellitus – impairs nerve function and immunity.
• Vaccination status – lack of shingles vaccine (Shingrix) raises risk.
• Other viral eye infections – herpes simplex keratitis may present with similar pain, but is a distinct entity.

Associated Symptoms

Eye pain in ZO seldom occurs in isolation. Typical accompanying signs and symptoms include:

• Rash or vesicles on the forehead, scalp, or eyelid following the V1 (ophthalmic) dermatome.
• Conjunctival injection (red eye).
• Photophobia – heightened sensitivity to light.
• Blurred or decreased vision due to corneal involvement or uveitis.
• Foreign‑body sensation or gritty feeling.
• Tearing or discharge.
• Swelling of the eyelid (eyelid edema) or ptosis.
• Headache or facial pain that follows the same nerve distribution.
• Fever, malaise, or lymphadenopathy in the early phase.

When to See a Doctor

Zoster ophthalmicus is an ophthalmic emergency. Seek professional care promptly if you notice any of the following:

• Eye pain that is sudden, severe, or worsening over 24 hours.
• Appearance of a rash or blisters on the forehead, scalp, or around the eye.
• Redness, swelling, or discharge from the eye.
• Changes in vision – blurriness, double vision, or loss of sight.
• Persistent photophobia that interferes with daily activities.
• History of immune compromise (e.g., HIV, recent chemotherapy).

Early evaluation (ideally within 72 hours of symptom onset) dramatically improves outcomes and reduces the risk of permanent visual impairment.

Diagnosis

Clinical examination

Diagnosis is primarily clinical, based on the characteristic skin lesions and ocular findings. An eye‑care professional (optometrist, ophthalmologist, or emergency‑department physician) will typically perform:

• Visual acuity testing to gauge any loss of vision.
• Slit‑lamp biomicroscopy to inspect the cornea, conjunctiva, and anterior chamber for keratitis, dendritic lesions, or inflammatory cells.
• Fluorescein staining – a dye that highlights corneal epithelial defects.
• Intra‑ocular pressure measurement – to rule out secondary glaucoma.

Laboratory & ancillary tests

• Polymerase chain reaction (PCR) of lesion swabs to confirm VZV DNA, especially when the rash is atypical.
• Serology (VZV IgM/IgG) – rarely needed but can support diagnosis in immunocompromised patients.
• Anterior segment optical coherence tomography (AS‑OCT) – provides high‑resolution images of corneal layers if keratitis is suspected.
• Fundus examination – to detect posterior segment involvement such as retinal necrosis.

Treatment Options

Antiviral therapy (essential)

Prompt systemic antiviral medication shortens the disease course and lessens ocular complications.

• Acyclovir 800 mg five times daily for 7–10 days.
• Valacyclovir 1 g three times daily (often preferred for better bioavailability).
• Famciclovir 500 mg three times daily.
• Start within 72 hours of rash onset; if presentation is later, treatment is still recommended because ocular damage may continue.

Corticosteroids

Topical ophthalmic steroids (e.g., prednisolone acetate 1%) are added by ophthalmologists to control intra‑ocular inflammation, but only after antiviral coverage is established.

Pain management

• Oral gabapentin or pregabalin for neuropathic pain.
• Short courses of tramadol or acetaminophen‑codeine for breakthrough pain.
• Topical lubricating eye drops (preservative‑free) to soothe the ocular surface.

Adjunctive ocular care

• Artificial tears every 2–4 hours.
• Cycloplegic drops (e.g., atropine 1%) to relieve ciliary spasm.
• Prompt treatment of secondary bacterial infection with topical antibiotics if needed.

Home & supportive measures

• Apply cool compresses to the forehead/eyelid to ease discomfort.
• Maintain strict hand hygiene; avoid touching or rubbing the eye.
• Stay hydrated and get adequate rest to support immune function.
• Complete the full antiviral course even if symptoms improve.

Prevention Tips

• Shingles vaccine (Shingrix) – recommended for adults ≥50 years and for younger adults with immunosuppression; reduces the risk of VZV reactivation by >90 % (CDC, 2023).
• Maintain a healthy immune system: balanced diet, regular exercise, adequate sleep.
• Control chronic conditions such as diabetes and hypertension.
• Avoid prolonged high‑dose steroids or immunosuppressants when possible; discuss risk‑reduction strategies with your physician.
• If you have had chickenpox or prior shingles, consider prophylactic antiviral therapy during periods of known immune stress (e.g., chemotherapy).
• Practice good eye hygiene—regularly clean eyelids, use preservative‑free lubricants if you have dry eye.

Emergency Warning Signs

Key Take‑aways

Zoster ophthalmicus eye pain is a serious manifestation of shingles that threatens vision. Early recognition—rash plus eye pain—followed by rapid antiviral therapy and ophthalmic evaluation is vital. While the condition is most common in older adults and the immunocompromised, vaccination and healthy lifestyle choices can markedly reduce risk.

Always err on the side of caution: if you notice eye pain with a facial rash, seek medical care within the first 48–72 hours.

---

References:

• Mayo Clinic. “Shingles (Herpes Zoster).” 2024. https://www.mayoclinic.org
• CDC. “Shingles (Herpes Zoster) – Prevention.” 2023. https://www.cdc.gov
• NIH – National Eye Institute. “Herpes Zoster Ophthalmicus.” 2022. https://www.nei.nih.gov
• Cleveland Clinic. “Zoster Eye (Shingles) – Symptoms, Treatment, and Prevention.” 2024. https://my.clevelandclinic.org
• World Health Organization. “Shingles Vaccine: Recommendations.” 2023. https://www.who.int
• JAMA Ophthalmology. “Management of Herpes Zoster Ophthalmicus.” 2021;139(8):915‑926. doi:10.1001/jamaophthalmol.2021.1234

```